Tdam USA Inc. lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 17.8% during the second quarter, Holdings Channel reports. The institutional investor owned 3,509 shares of the medical research company’s stock after selling 760 shares during the period. Tdam USA Inc.’s holdings in Agilent Technologies were worth $206,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Skandinaviska Enskilda Banken AB publ increased its stake in shares of Agilent Technologies by 5.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock valued at $3,428,000 after buying an additional 3,489 shares in the last quarter. British Columbia Investment Management Corp increased its stake in shares of Agilent Technologies by 96.7% in the first quarter. British Columbia Investment Management Corp now owns 357,983 shares of the medical research company’s stock valued at $18,927,000 after buying an additional 175,992 shares in the last quarter. Wesbanco Bank Inc. bought a new stake in shares of Agilent Technologies during the first quarter valued at $215,000. Creative Planning increased its stake in shares of Agilent Technologies by 6.3% in the first quarter. Creative Planning now owns 11,961 shares of the medical research company’s stock valued at $632,000 after buying an additional 710 shares in the last quarter. Finally, Henderson Group PLC increased its stake in shares of Agilent Technologies by 2.2% in the first quarter. Henderson Group PLC now owns 37,408 shares of the medical research company’s stock valued at $1,978,000 after buying an additional 800 shares in the last quarter.
Agilent Technologies, Inc. (NYSE A) opened at 58.57 on Friday. The firm’s 50-day moving average is $60.14 and its 200-day moving average is $55.60. The stock has a market cap of $18.82 billion, a P/E ratio of 32.92 and a beta of 1.30. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $61.84.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.10. Agilent Technologies had a net margin of 13.41% and a return on equity of 16.49%. The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same period in the previous year, the business earned $0.44 earnings per share. The company’s revenue was up 8.1% on a year-over-year basis. On average, equities analysts forecast that Agilent Technologies, Inc. will post $2.23 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 26th. Investors of record on Monday, July 3rd were issued a dividend of $0.132 per share. This represents a $0.53 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date of this dividend was Thursday, June 29th. Agilent Technologies’s payout ratio is currently 29.78%.
COPYRIGHT VIOLATION WARNING: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/2802491/agilent-technologies-inc-a-stake-decreased-by-tdam-usa-inc.html.
Several analysts recently commented on A shares. Deutsche Bank AG reiterated a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research report on Thursday, June 22nd. Morgan Stanley upped their price target on shares of Agilent Technologies from $65.00 to $70.00 and gave the company an “overweight” rating in a research report on Wednesday, May 24th. BTIG Research upped their price target on shares of Agilent Technologies from $57.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, May 24th. BidaskClub downgraded shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Finally, Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $63.00 price target for the company in a research report on Tuesday, May 16th. Two research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $60.12.
In related news, Director Heidi Fields sold 8,625 shares of Agilent Technologies stock in a transaction dated Friday, June 16th. The stock was sold at an average price of $59.53, for a total transaction of $513,446.25. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of Agilent Technologies stock in a transaction dated Thursday, July 13th. The stock was sold at an average price of $61.26, for a total value of $306,300.00. Following the transaction, the insider now directly owns 45,138 shares in the company, valued at $2,765,153.88. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 112,608 shares of company stock worth $6,737,509.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.